Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1714 results
three silver clocks in an open space with people walking passed

A new study suggests that people under the age of 55 may be biologically ageing faster than people who are older. And this trend could be linked to the rise in early-onset cancers. A new study suggests that people under the age of 55 may be biologically ageing faster than people who are older. And this trend could be linked to the rise in early-onset cancers.

by Sydney Ghazarian | Analysis | 30 June 2026

30 June 2026

An image of a radiotherapy machine. Its lights are glowing blue.

Based on our research, NHS England will use stereotactic ablative radiotherapy (SABR) to treat many early-stage prostate cancers in five sessions, rather than 20.  Based on our research, NHS England will use stereotactic ablative radiotherapy (SABR) to treat many early-stage prostate cancers in five sessions, rather than 20. 

by Tim Gunn | News | 17 June 2026

17 June 2026

A group of microscopic glioblastoma cells against a black background. The cells are coloured red, with their steroid receptors marked in green.

Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet. Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet.

by Fiona MacLeod, Tim Gunn | Analysis | 20 February 2026

20 February 2026

A woman facing away from the camera looks at medicine on pharmacy shelves.

With our funding, researchers at Imperial College London are investigating whether we can look for patterns in the medicines people buy to identify very early-stage cancers. With our funding, researchers at Imperial College London are investigating whether we can look for patterns in the medicines people buy to identify very early-stage cancers.

by Tim Gunn | News | 2 February 2026

2 February 2026

A computer generated microscopic image of purple lung cancer cells with a genetic mutation.
  • Science & Technology
  • Health & Medicine

Our defining research stories of 2025

2025 has been a huge year for research at Cancer Research UK. To celebrate, we've brought together our most defining research stories of the year. 2025 has been a huge year for research at Cancer Research UK. To celebrate, we've brought together our most defining research stories of the year.

by Amal Iman | In depth | 19 December 2025

19 December 2025

A patient and a GP having a discussion in the GP's office.

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

by Cancer Research UK | Analysis | 28 November 2025

28 November 2025

2D image of scientist hands with a cancer vaccine vial and needle
  • Science & Technology
  • Health & Medicine

Cancer Vaccines - where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever? Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever?

by Sophie Wedekind | In depth | 20 November 2025

20 November 2025

A microscopic image of two lung cancer cells dividing, held together by a very thin bridge of cytoplasm.

With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine. With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine.

by Amal Iman | News | 17 November 2025

17 November 2025